Riina Sikkut
Tervise- ja tööminister
Sotsiaalministeerium 08.02.2019
nr 10.1-13/218-1
Tarmo Tamm
Maaeluminister
Maaeluministeerium
Austatud ministrid
Edastame teile Euroopa Komisjoni voliniku Vytenis Andriukaitise 06.02.2019 kirja
(Implementation of the Regulation (EU) 2019/6 on veterinary medicinal products and repealing
Directive 2001/82/EC).
Lugupidamisega
Clyde Kull
Suursaadik, esinduse asejuht Coreper I küsimustes
Lisad: 1) voliniku kiri, 2 lk
Tiiu Noobel, +32 2227 4337,
[email protected]
Rue Guimard 11/13 / B-1040 Brüssel / Belgia
Tel: +32 2 227 39 10 /
[email protected] / http://www.eu.estemb.be
European
Commission
Vytenis ANDRIUKAITIS Beri 08/369
Member of the European Commission ^ue '-0'·
B-1049 Brussels - Belgium
Tel. 00.32.2.295.41.59
e-mail:
[email protected]
Ms Riina SIKKUT Brussels, 0 6, 02. 2019
Estonian Minister of Health and Labour ARES(2019)
Mr Tarmo TAMM
Estonian Minister for Rural Affairs
Dear Ministers,
I am writing in relation to Regulation (EU) 2019/6 of the European Parliament and of the Council of
II December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4,
7.1.2019, p. 43, hereinafter: the new Regulation), which entered into force on 28 January.
First, let me personally thank you for all the hard work and kind support that you provided during the
negotiations of the text of the new Regulation.
The 4 years of discussions between the co-legislators brought about many improvements to the initial
Commission proposal of 2014. Thanks to the invaluable input from the Member States within the
Council, the text of the new Regulation provides for a legal framework on veterinary medicines which
is modem, innovative, fit for purpose and an important contribution to the fight of antimicrobial
resistance.
The new Regulation now foresees some 25 implementing and delegated acts, many of which will be
adopted by the date of application. The Regulation also foresees the development of a product database
and data management system of two other databases to the current standards of electronic
communication and interaction.
Therefore, the work on the implementation of the new Regulation needs to start immediately.
The Commission has started planning and organising work along the legal deadlines foreseen in the
new Regulation. It emerges that we will need to work in parallel on several aspects. On 14 December
2018 we met with the representatives of the Member States within the framework of the relevant
expert group and Standing Committee. We presented and explained the detailed implementation plan
for the new Regulation. Likewise, scientific advice will soon be sought from the European Medicines
Agency and Member States’ scientific experts in preparation of the implementing and delegated acts.
In the same vein, I would like to make a strong point about the resources, both human and financial,
that the implementation of the new Regulation will require. The Commission very much relies on the
Member States to make available the expertise and resources necessary to successfully translate into
practice the rules and measures laid down in the new Regulation. We need to work closely together on
all the implementing and delegated acts foreseen in the new Regulation, in order to render the new
Regulation operational.
To this end, I would like to direct your particular attention to the national contribution to the Union
product database, which is a crucial element of the new Regulation. It will necessitate considerable
input and cooperation on the part of the Member States to get the national databases set up or, where
already in place, aligned to keep up to date the future Union product database. In the interest of public
and animal health as well as availability of veterinary medicinal products, efficient national IT systems
should be operable and interoperable with the future Union product database by early 2022, which is
why appropriate resources should be reserved in time by Member States to ensure delivery
accordingly. Over the coming months, the Commission together with EMA will assess and define
what additional IT architecture is needed to ensure the functionality of the future Union product
database and its interoperability with the national IT systems.
I count on your support and efforts to ensure that these implementing measures, which the veterinary
sector has awaited and to which it attaches particular importance, will be adopted as timely and swiftly
as possible.
My colleagues in the Directorate-General for Health and Food Safety of the European Commission
and I personally are strongly committed to successfully delivering on the implementation work for the
new Regulation. We remain available and willing to support the Member States in their work.
Yours sincerely,
Electronically signed on 06/02/2019 13:31 (UTC+01) in accordance with article
2 4.2 (Validity of electronic documents) of Commission Decision 2004/563
Tiiu Noobel
From:
[email protected]
Sent: neljapäev, 7. veebruar 2019 15:17
To: Esindus EL juures üldaadress
Cc:
[email protected]; Elen Nurme
Subject: EE - Letter from Commissioner Andriukaitis
Attachments: Letter to EE.pdf
For attention of Mr Clyde Kull, Deputy Permanent Representative
Please find enclosed a letter from EU Commissioner Andriukaitis addressed to the Minister of Social
Affairs and the Minister for Rural Affairs of Estonia.
Kind regards,
Kristina Bradaityte
Secretary to Ms Annika Nowak,
Mr Arunas Ribokas, Mr Nicolas Pradalié
Cabinet of Commissioner Vytenis Andriukaitis
Health and Food Safety
EUROPEAN COMMISSION
BERL 08/350
BE-1049 Brussels
+32-(0)2-29 6 90 91
[email protected]
1